Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Kidney Neoplasms × Hydromorphone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain 10 Neoplasms 4 Hematologic Neoplasms 2 Emergencies 2 Cancer Pain 2 Tumor Surgery 1 Rectal Neoplasms 1 Pulmonary Nodule 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain, Intractable 1 Neoplasm Metastasis 1 Mucositis 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Follicular 1 Leukemia 1 Kidney Neoplasms 1 Intraoperative Complications 1 Ileus 1 Duodenal Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Digestive System Diseases 1 Constipation 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Bone Marrow Failure Disorders 1 Anemia, Aplastic 1

Interventions

aldesleukin 37 Sunitinib 34 Cyclophosphamide 27 Nivolumab 25 Interferon-alpha 25 pembrolizumab 24 Everolimus 24 Sorafenib 18 Bevacizumab 18 fludarabine phosphate 17 Interleukin-2 17 Ipilimumab 15 Peripheral Blood Stem Cell Transplantation 14 Filgrastim 14 cabozantinib 13 Gemcitabine 13 Axitinib 13 Radiotherapy 11 temsirolimus 10 fludarabine 10 Radiosurgery 10 Doxorubicin 9 Carboplatin 9 sargramostim 8 belzutifan 8 Fluorouracil 8 Etoposide 8 Chemotherapy, Adjuvant 8 Magnetic Resonance Spectroscopy 7 pazopanib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05842044 2025-09-05

No-PAIN

University of Miami

Phase 2 Recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡